Daejeon, South Korea

Hyo Kon Chun

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyo Kon Chun. Retrieved from https://idiyas.com/inventor/hyo-kon-chun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Inflammatory Disease Treatment by Hyo Kon Chun

Introduction

Hyo Kon Chun is a notable inventor based in Daejeon, South Korea, with a focus on developing innovative pharmaceutical solutions. His work has led to the creation of a significant patent that addresses inflammatory diseases, showcasing his commitment to advancing healthcare and therapeutic methods.

Latest Patents

Hyo Kon Chun holds a patent related to "2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same." This invention presents a novel class of compounds that are specifically designed for preventing and treating various inflammatory diseases, including rheumatoid arthritis, gout, and inflammatory Crohn's disease. The pharmaceutical compositions he developed can serve as effective therapeutics aimed at alleviating pain and inflammation associated with these conditions.

Career Highlights

Currently, Hyo Kon Chun is associated with the Korea Research Institute of Bioscience and Biotechnology. His role at the institute allows him to collaborate with leading scientists and contribute to transformative research in biomedicine. His patent reflects not only his inventiveness but also his dedication to improving patient outcomes through innovative therapies.

Collaborations

Hyo Kon Chun has worked alongside esteemed colleagues such as Yung Hee Kho and Gyoon Hee Han. These collaborations have facilitated a multidisciplinary approach to his research, enhancing the development and efficacy of his patented innovations.

Conclusion

Hyo Kon Chun's contributions to the field of pharmaceuticals, particularly in the realm of inflammatory disease treatment, mark him as a significant figure in contemporary biomedical research. Through his innovations, he is paving the way for new therapeutic options that can significantly improve the quality of life for patients suffering from chronic inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…